ArticleDiabetes, obesity & metabolism2026
Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsManaging blood pressure (BP) in older adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) remains controversial, particularly regarding optimal targets and the impact of inadequate monitoring. Using Clinical Practice Research Datalink (CPRD) data, this study assessed associations between baseline systolic and diastolic BP (SBP and DBP) and the risk of major adverse cardiovascular events (MACE) and mortality in adults aged ≥65 with both T2D and CKD, the impact of missing BP records (proxy for inadequate monitoring), and sex-based differences in these relationships. MATERIALS AND
methodsA retrospective cohort study was conducted using CPRD data. The primary outcome was MACE (nonfatal stroke, myocardial infarction, and cardiovascular death); the secondary outcome was all-cause mortality. Baseline BP was modelled continuously and categorised as high (≥140/90 mmHg), normal (<140/90 mmHg), or missing (no BP record within 2 years prior to diagnosis). Flexible parametric competing risks models estimated adjusted 5-year outcome risks.
resultsMACE analysis included 160 764 individuals; mortality analysis included 181 307. The 5-year MACE risk was 14.1% for normal, 13.8% for high, and 19.6% for missing SBP. For all-cause mortality, risks were 20.6% (normal), 19.4% (high), and 34.0% (missing). SBP was a stronger risk indicator than DBP for both outcomes. Lower SBP (120 mmHg) was moderately associated with increased MACE and mortality; higher DBP (90 mmHg) was linked to increased mortality. Men had higher MACE and mortality risks than women.
conclusionsIn older adults with T2D and CKD, lower SBP and DBP were moderately associated with a higher risk of MACE and mortality, but the strongest indicator of adverse outcomes was the absence of regular blood pressure monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.